Oral Route of Administration Remains More Preferred for Anti-Osteoporosis Therapy and Fracture Healing, Accounting for Over 64% of Sales in North America
Dubai, United Arab Emirates - March 12, 2021 /MarketersMedia/ —
According to the National Osteoporosis Foundation, there has been a substantial increase in osteoporosis incidence among postmenopausal women due to calcium deficiency. This is driving the market for anti-osteoporosis therapy and fracture healing.
Future Market Insights, Dubai: FMI has projected the anti-osteoporosis therapy and fracture healing-market to record a CAGR of 3% through 2030. The demand for anti-osteoporosis therapy and fracture healing treatment is anticipated to continue surging due to the rising demand for non-invasive therapeutics.
“Key players are adopting merger and acquisition strategies for increasing their presence across the globe,” says the FMI analyst.
Anti-Osteoporosis Therapy And Fracture Healing treatment Market - Important Highlights
• Bisphosphonates will remain the preferred drug type due to the growing adaptation to target-specific treatments
• The oral route of administration is expected to remain most preferred
• Profit from hospital pharmacy is projected to grow by 2X by 2030 compared to 2019.
• The U.S. is leading the global market for anti-osteoporosis treatment and fracture healing, with revenues estimated to exceed US$ 6.3 billion by 2030
Request a report sample to gain comprehensive market insights at
https://www.futuremarketinsights.com/reports/sample/rep-gb-1008
Anti-Osteoporosis Therapy And Fracture Healing Treatment Market – Drivers
• Increase in geriatric population, who are at high risk of osteoporosis, is driving the market
• The increasing pace of drug approval and commercialization are enabling growth
• Increasing investment in innovation and new product launches are expected to boost the market
Anti-Osteoporosis Therapy and Fracture Healing Treatment Market – Restraints
• Significantly less understanding of osteoporosis and its treatment choices in GCC countries is hindering the growth of the market.
• Poor economic conditions and healthcare infrastructure might hinder the adoption of anti-osteoporosis therapy and fracture healing treatment across some countries
COVID-19 Impact on Anti-Osteoporosis Therapy And Fracture Healing treatment Market
During this time there has been a disruption in the supply and demand chain which has caused an impact on the revenue of the Anti-Osteoporosis Therapy And Fracture Healing treatment in a negative way. However, this is estimated to be a temporary effect and the market is expected to have a turnaround. The pandemic has led to a decrease in the patient's flow in the hospitals, and doctor chambers. This has caused a reduction in the number of surgeries and that in turn has affected the Anti-Osteoporosis Therapy And Fracture Healing treatment market.
Get Access to Research Methodology Prepared by Experts>>> https://www.futuremarketinsights.com/ask-question/rep-gb-1008
Competitive Landscape
Key companies are aiming at strategic collaboration. The Anti-osteoporosis treatment and fracture healing industry is a relatively consolidated market with fewer than 10 market players comprising more than 50% of the overall revenue.
Some of the leading companies operating in the market are Eli Lilly and Company, Pfizer Inc., Amgen Inc., Merck and Company, Inc., Novartis International AG, F. Hoffmann La Roche Ltd.
About the Study
The study offers readers a comprehensive assessment of the Anti-Osteoporosis Therapy And Fracture Healing treatment market. Global, regional, and national-level analysis of the latest trends influencing the market is covered in this FMI report. The study provides insights based on drug class (Bisphosphonates, Calcitonin, Estrogen or Hormone Replacement Therapy), route of administration (oral, injectable), distribution channel (Hospital Pharmacies, Retail Pharmacies, Online sales), and across key regions (North America, Latin America, Europe, China, Asia Pacific, Middle East & Africa).
Explore FMI’s Coverage of the healthcare Industry
Rapid Infuser Market: Get insights on the rapid infuser market through FMI’s report covering detailed quantitative and qualitative analysis for the projection period 2020-2030.
Medical face shield market: FMI’s exhaustive study on the medical face shield market covers the latest trends, innovations, key players, and popular strategies for the period 2020-2030.
laryngoscopes market: Obtain detailed analysis on the Laryngoscopes market through FMI’s report covering competitive analysis, key regions, and segmental analysis for 2020-2030.
About Future Market Insights
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers
Contact Info:
Name: Abhishek Budholiya
Email: Send Email
Organization: Future Market Insights
Address: 1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A, Jumeirah Lakes Towers, Dubai, United Arab Emirates
Phone: +1-347-918-3531
Website: https://www.futuremarketinsights.com/reports/anti-osteoporosis-therapy-and-fracture-healing-market
Source: MarketersMedia
Release ID: 89000763
